Literature DB >> 5915585

Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases.

D J Ward, M Hartog, B M Ansell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5915585      PMCID： PMC2453455          DOI： 10.1136/ard.25.5.416

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONE.

Authors:  M HARTOG; M A GAAFAR; R FRASER
Journal:  Lancet       Date:  1964-08-22       Impact factor: 79.321

2.  THE EFFECT OF HUMAN GROWTH HORMONE IN HYPOPITUITARY DWARFISM.

Authors:  A PRADER; R ILLIG; J SZEKY; H WAGNER
Journal:  Arch Dis Child       Date:  1964-12       Impact factor: 3.791

3.  The effects of intermittent doses of adrenocortical steroids on the statural growth of nephrotic children.

Authors:  D S FLEISHER; W W McCRORY; M RAPOPORT
Journal:  J Pediatr       Date:  1960-08       Impact factor: 4.406

4.  Growth rate of children with intractable asthma. Observations on the influence of the illness and its therapy with steroids.

Authors:  C J FALLIERS; J SZENTIVANYI; M McBRIDE; S C BUKANTZ
Journal:  J Allergy       Date:  1961 Sep-Oct

5.  A specific method for the analysis of hydroxyproline in tissues and urine.

Authors:  D J PROCKOP; S UDENFRIEND
Journal:  Anal Biochem       Date:  1960-11       Impact factor: 3.365

6.  Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children.

Authors:  F M BLODGETT; L BURGIN; D IEZZONI; D GRIBETZ; N B TALBOT
Journal:  N Engl J Med       Date:  1956-04-05       Impact factor: 91.245

7.  Growth in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103
  7 in total
  12 in total

1.  Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.

Authors:  D W Zutshi; M Friedman; B M Ansell
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

2.  Growth hormone studies in patients with rheumatoid arthritis with or without glucocorticoid therapy.

Authors:  O Butenandt; A Kelch; E Rajmann
Journal:  Z Kinderheilkd       Date:  1974

3.  Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.

Authors:  C N Lam; G C Arneil
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

4.  Hydroxyproline excretion in various forms of growth failure.

Authors:  W M Teller; U Genscher; H Burkhardt; K Rommel
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

5.  Problems of corticosteroid therapy in the young.

Authors:  B M Ansell
Journal:  Proc R Soc Med       Date:  1968-03

6.  Valgus knee deformities in children with juvenile chronic polyarthritis treated by epiphysial stapling.

Authors:  B M Ansell; G P Arden; I McLennan
Journal:  Arch Dis Child       Date:  1970-06       Impact factor: 3.791

7.  Acute metabolic response to human growth hormone in different types of dwarfism.

Authors:  K E Melvin; A D Wright; M Hartog; A C Antcliff; A M Copestake; T R Fraser
Journal:  Br Med J       Date:  1967-07-22

8.  Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone.

Authors:  O Butenandt
Journal:  Eur J Pediatr       Date:  1979-01-18       Impact factor: 3.183

9.  Effect of administered human growth hormone on growth retardation in inflammatory bowel disease.

Authors:  T D McCaffery; K Nasr; A M Lawrence; J B Kirsner
Journal:  Am J Dig Dis       Date:  1974-05

10.  Somatic growth in corticosteroid-treated rats with passive Heymann nephritis--effects of recombinant human growth hormone on growth impairment.

Authors:  H Kawaguchi; M Hattori; M Kohno; K Ito; N Hizuka; K Takano
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.